BUSINESS● LOW1h ago · Sep 21, 2026, 8:31 AM
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
CNBC · global
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS15m agoEU Fines Google £403m For Data Location BreachChannels TVBUSINESS21m agoBiggest stock movers Monday: WBD, PSKY, and moreSeeking Alpha Tech